COVID Vaccine Made With Plants? It's The Subject Of Clinical Trial In Wilmington

By Cece Nunn, posted Apr 12, 2021
Trial Management Associates, a Wilmington clinical research firm, and Bart Williams and Will Jones of Wrightsville Family Practice are conducting a trial of a new COVID-19 vaccine using plant-based technology and plant cells, according to an announcement Monday.

Williams, the physician overseeing the trial, said in the news release, “The health and safety of our community continues to be the basis for our research. Finding safe and effective COVID-19 vaccines and having a community comfort level to actually receive the vaccine will be the main way we navigate out of this global pandemic.

"Some patients in our community are hesitant to receive the current COVID-19 vaccines approved by the FDA. We worked hard to secure this trial because the plant-based technology offers an alternative, and everyone who participates in the trial will ultimately receive the vaccine.”

Phil Dattilo, president of TMA, said his firm's mission is to bring as many therapies to the Wilmington community as possible. He could not say which company his firm is working with on the trial.

Dattilo said creating vaccines using plants isn't new.

"Plant-based vaccines have been around for quite some time for various uses, such as influenza A and influenza B vaccines," he said.

Explaining how the vaccine works, TMA’s pharmacist Evan Lucas said in the release, “The vaccine for this study is plant-based, meaning that it is produced inside of plants and plant cells instead of animal or human cells as many vaccines are.

"The plants produce virus-like particles, which look very similar to coronavirus but do not make you sick. These particles trigger the immune system to respond and produce antibodies, helping patients develop immunity against COVID-19.”

TMA is seeking up to 330 volunteers ages 18 and older, who have not already received a COVID vaccination, to participate in the study. Potential patients may have received other types of vaccines if they have done so 14 days prior to starting the study and may receive other vaccines 28 days after receiving the study vaccine.

The trial requires five in-office visits, and all patients will be compensated for their time and travel. Those who want to participate in Wilmington or the surrounding communities can contact TMA at [email protected] or call 247-4580.
Ico insights


Chris coudriet

Connecting Resources For Safer Schools And Community

Chris Coudriet - New Hanover County Government
Mel profilephoto

Influencer Marketing: Tap Into Your Audience On A Budget

Mel Beasley - Wide Open Tech
Mikestonestreetcropped 862150530

Heading Back To Class: The Importance Of Board Member Education

Mike Stonestreet - CAMS (Community Association Management Services)

Trending News

UNCW's Chancellor Sartarelli Plans To Retire

Cece Nunn - Sep 24, 2021

Woody White Blasts UNCW After Resigning As Trustee

Cece Nunn - Sep 24, 2021

Custom Builder Moves Into New Office After Repurposing Former Church Building

Cece Nunn - Sep 23, 2021

Long-vacant Wrightsville Ave. Properties Coming Back To Life

Cece Nunn - Sep 23, 2021

New Launch Date Announced For TRU Colors Beer

Johanna Cano - Sep 23, 2021

In The Current Issue

Trailblazing Builder Hangs Up Her Hard Hat

Beth Pancoe, 81, became one of the first licensed female contractors in Eastern North Carolina in 1987 and built a company focused on histor...

Store Owners Share Basketful Of Hopes

Not only will it offer fresh, locally sourced meats, produce and dairy products, but the business will also have an open kitchen where baked...

MADE Winners: Exporter Category

HSM Machine Works, Marpac Yogasleep and SOS Life Sciences Corp. were winners in the MADE Awards Exporter Category....

Book On Business

The 2021 WilmingtonBiz: Book on Business is an annual publication showcasing the Wilmington region as a center of business.

Order Your Copy Today!



Trying to Grow a Business?
2020 Health Care Heroes
2020 WilmingtonBiz 100